Linked Life Data

10748696

Source:http://linkedlifedata.com/resource/pubmed/id/10748696

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2000-4-14
pubmed:abstractText
New psychopharmacological studies performed these last few years should allow, in future, to improve methadone prescription. In particular, thanks to the identification of enzymes involved in the metabolism of this molecule, it is now possible to better understand the problems of metabolic interactions, to foresee and to avoid them. Studies showing the influence of genetic and environmental factors on blood concentrations of methadone, as well as a recent clinical study performed with methadone doses largely in excess of 100 mg/day, stress the importance of adapting methadone treatment individually, particularly as regards to the choice of the dose. This choice must not result from an administrative standardization, as it is essential for patients that, with an adequate social and psychological treatment, an adequate pharmacological treatment should be associated.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0035-3655
pubmed:author
pubmed:issnType
Print
pubmed:volume
120
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
111-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
[New psychopharmacologic studies on methadone: implications for the treatment of opiate dependency].
pubmed:affiliation
Département universitaire de psychiatre adulte, Hôpital de Cery, Prilly-Lausanne, Switzerland. Chin.Eap@inst.hospvd.ch
pubmed:publicationType
Journal Article, English Abstract, Research Support, Non-U.S. Gov't